New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
-14.97%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$76.6B
AUM Growth
-$16.9B
(-18%)
Cap. Flow
-$991M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
3,646
New
299
Increased
1,012
Reduced
2,108
Closed
73
Top Buys
| 1 |
Linde
LIN
|
$242M |
| 2 |
ConocoPhillips
COP
|
$73.9M |
| 3 |
Airbnb
ABNB
|
$57.9M |
| 4 |
Salesforce
CRM
|
$52.5M |
| 5 |
Chevron
CVX
|
$52M |
Top Sells
| 1 |
Apple
AAPL
|
$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$104M |
| 3 |
AT&T
T
|
$99.3M |
| 4 |
UnitedHealth
UNH
|
$80.8M |
| 5 |
NXP Semiconductors
NXPI
|
$65.7M |
Sector Composition
| 1 | Technology | 24.72% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 13.42% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Kartoon Studios
TOON
$38.5M
| $1K | ﹤0.01% |
184
-18,175
| -99% | -$98.8K |
|
3377
Entrada Therapeutics
TRDA
$201M
| $1K | ﹤0.01% |
109
-4,771
| -98% | -$43.8K |
|
3378
Telesat
TSAT
$342M
| $1K | ﹤0.01% |
66
-7,743
| -99% | -$117K |
|
3379
Taysha Gene Therapies
TSHA
$917M
| $1K | ﹤0.01% |
191
-14,100
| -99% | -$73.8K |
|
3380
TherapeuticsMD
TXMD
$12.5M
| $1K | ﹤0.01% |
71
-4,742
| -99% | -$66.8K |
|
3381
UroGen Pharma
URGN
$873M
| $1K | ﹤0.01% |
174
-13,400
| -99% | -$77K |
|
3382
INNOVATE Corp
VATE
$75.2M
| $1K | ﹤0.01% |
30
-1,410
| -98% | -$47K |
|
3383
VirnetX
VHC
$78.5M
| $1K | ﹤0.01% |
27
-1,095
| -98% | -$40.6K |
|
3384
Viking Therapeutics
VKTX
$3.03B
| $1K | ﹤0.01% |
452
-58,652
| -99% | -$130K |
|
3385
Vor Biopharma
VOR
$248M
| $1K | ﹤0.01% |
190
-10,504
| -98% | -$55.3K |
|
3386
Wave Life Sciences
WVE
$1.32B
| $1K | ﹤0.01% |
353
-21,600
| -98% | -$61.2K |
|
3387
XBiotech
XBIT
$89M
| $1K | ﹤0.01% |
140
-6,312
| -98% | -$45.1K |
|
3388
Exagen
XGN
$213M
| $1K | ﹤0.01% |
97
-6,800
| -99% | -$70.1K |
|
3389
Xoma
XOMA
$426M
| $1K | ﹤0.01% |
50
-5,600
| -99% | -$112K |
|
3390
Zevra Therapeutics
ZVRA
$502M
| $1K | ﹤0.01% |
181
-13,171
| -99% | -$72.8K |
|
|
LENZ
3391
LENZ Therapeutics
LENZ
$1.2B
| $1K | ﹤0.01% |
41
-3,393
| -99% | -$82.8K |
|
3392
Q32 Bio
QTTB
$20.4M
| $1K | ﹤0.01% |
20
-1,350
| -99% | -$67.5K |
|
|
RPT
3393
Rithm Property Trust Inc.
RPT
$121M
| $1K | ﹤0.01% |
137
-15,366
| -99% | -$112K |
|
|
NAGE
3394
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
| $1K | ﹤0.01% |
390
-19,888
| -98% | -$51K |
|
|
VOXX
3395
DELISTED
VOXX International Corporation Class A
VOXX
| $1K | ﹤0.01% |
128
-10,800
| -99% | -$84.4K |
|
|
SYRS
3396
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1K | ﹤0.01% |
62
-3,360
| -98% | -$54.2K |
|
|
OMGA
3397
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1K | ﹤0.01% |
230
-18,790
| -99% | -$81.7K |
|
|
GATO
3398
DELISTED
Gatos Silver, Inc.
GATO
| $1K | ﹤0.01% |
303
-27,607
| -99% | -$91.1K |
|
|
PSTX
3399
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1K | ﹤0.01% |
307
-11,665
| -97% | -$38K |
|
|
NH
3400
DELISTED
NantHealth, Inc
NH
| $0 | ﹤0.01% |
17
-494
| -97% | – |
|